Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Tran

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
Journal of Hepatology|July 24, 2012
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgeryRodolphe Anty, Sophie Marjoux, Antonio Iannelli, et al.
International Journal of Molecular Sciences|March 13, 2024
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse ModelPhoebe Ohene-Marfo, Hoang Van M Nguyen, Sabira Mohammed, et al.
Journal of Hepatology|January 18, 2011
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patientsEsther Zimmermann, Rodolphe Anty, Joan Tordjman, et al.
Journal of Hepatology|March 22, 2017
CD44 is a key player in non-alcoholic steatohepatitisStéphanie Patouraux, Déborah Rousseau, Stéphanie Bonnafous, et al.
Therapeutic Drug Monitoring|August 26, 2016
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon RibavirinVéronique Loustaud-Ratti, Marianne Maynard, Sylvie Thevenon, et al.
Journal of Viral Hepatitis|May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohortVictor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.
World Journal of Hepatology|April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatientsJean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLDPhoebe Ohene-Marfo, Sabira Mohammed, Chao Jiang, et al.
The American Journal of Gastroenterology|June 23, 2006
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASHRodolphe Anty, Soumeya Bekri, Nathalie Luciani, et al.
Endocrinology|December 19, 2014
Hypoxia inhibits Cavin-1 and Cavin-2 expression and down-regulates caveolae in adipocytesClaire Regazzetti, Karine Dumas, Sandra Lacas-Gervais, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Journal of Hepatology|July 24, 2012
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgeryRodolphe Anty, Sophie Marjoux, Antonio Iannelli, et al.
International Journal of Molecular Sciences|March 13, 2024
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse ModelPhoebe Ohene-Marfo, Hoang Van M Nguyen, Sabira Mohammed, et al.
Journal of Hepatology|January 18, 2011
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patientsEsther Zimmermann, Rodolphe Anty, Joan Tordjman, et al.
Journal of Hepatology|March 22, 2017
CD44 is a key player in non-alcoholic steatohepatitisStéphanie Patouraux, Déborah Rousseau, Stéphanie Bonnafous, et al.
Therapeutic Drug Monitoring|August 26, 2016
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon RibavirinVéronique Loustaud-Ratti, Marianne Maynard, Sylvie Thevenon, et al.
Journal of Viral Hepatitis|May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohortVictor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.
World Journal of Hepatology|April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatientsJean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLDPhoebe Ohene-Marfo, Sabira Mohammed, Chao Jiang, et al.
The American Journal of Gastroenterology|June 23, 2006
The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASHRodolphe Anty, Soumeya Bekri, Nathalie Luciani, et al.
Endocrinology|December 19, 2014
Hypoxia inhibits Cavin-1 and Cavin-2 expression and down-regulates caveolae in adipocytesClaire Regazzetti, Karine Dumas, Sandra Lacas-Gervais, et al.
Pageof 19